Monroe Dispatch - No Struggle, No Progress

COVID-19 Vaccine Clinical Trials in Northeast Louisiana

 

August 6, 2020



Participants are now being accepted to be part of a national COVID-19 vaccine clinical trial coordinated in our area through Monroe-based Clinical Trials of America (CTA). Pharmaceutical company AstraZeneca is conducting the trials beginning this month while over 30,000 have participated in Phase III thus far. CTA CEO Jeb Andrews, PhD, states that they are honored to have been selected to secure the 1,500 participants in northeast Louisiana, and that two-thirds of the participants will receive the live vaccine while the remaining receive a placebo. Dr. Andrews noted that typically trials li...



For access to this article please sign in or subscribe.



 

Reader Comments
(0)

 
 

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020